LUCERNA INC
Cell-based high-throughput screening platform that directly monitors DNA-dependent RNA Polymerase I transcription using proprietary RNA aptamer technology to identify cancer therapeutics
- Sector
- Biotech
- Headquarters
- New York, NY
- Total capital
- $11.6M
- Federal grants
- $9.8M
- 27 awards · 2015–2025
- Rank in peer group#22 of 36
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $1.8M
- 2 awards · Health and Human S
- Rank in Biotech#145 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · In vivo imaging platform for DM1 drug discovery$313K
- Federal grantHealth and Human S · Phase I · Targeted RNA degradation assay for new antiviral drug discovery$300K
- Federal grantHealth and Human S · Phase I · Cell-based RNA degradation assay for C9ALS/FTD drug discovery$392K
- Federal grantHealth and Human S · Phase II · Fluorescent IRE sensor for synucleinopathy drug discovery$874K
- Federal grantHealth and Human S · Phase II · Fluorescent IRE Sensor for Synucleinopathy Drug Discovery$854K
- Federal grantHealth and Human S · Phase I · Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery$224K
- Federal grantHealth and Human S · Phase I · Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery$224K
Show 21 earlier federal awards
- Federal grantHealth and Human S · Phase II · Splice sensors for cancer drug discovery$533K
- Federal grantHealth and Human S · Phase I · Cell-based assay directly monitoring viral polymerase activity for drug discovery.$224K
- Federal grantHealth and Human S · Phase I · Cell-based assay directly monitoring viral polymerase activity for drug discovery.$224K
- Federal contractHealth and Human S · Topic 356: Fluorogenic Assay Platform For Circular Rna Detection$1.5M
- Federal grantHealth and Human S · Phase II · Splice sensors for cancer drug discovery$355K
- Federal grantHealth and Human S · Phase I · New high-throughput screening technologies to improve cannabinoid production in yeast.$225K
- Federal grantHealth and Human S · Phase I · New high-throughput screening technologies to improve cannabinoid production in yeast.$225K
- Federal grantHealth and Human S · Phase I · Assay Classifier Engine (ACE) for enhancing splice sensor assay performance$225K
- Federal grantHealth and Human S · Phase I · Assay Classifier Engine (ACE) for enhancing splice sensor assay performance$225K
- Federal grantHealth and Human S · Phase I · Cell-based viral helicase assay for dengue drug discovery$224K
- Federal grantHealth and Human S · Phase I · Fluorescent IRE sensor for PD drug discovery$222K
- Federal grantHealth and Human S · Phase I · Cell-based viral helicase assay for dengue drug discovery$224K
- Federal grantHealth and Human S · Phase II · Splice sensors for cancer drug discovery$1.5M
- Federal grantHealth and Human S · Phase II · Splice sensors for cancer drug discovery$603K
- Federal contractHealth and Human S · Igf::ot::igf SBIR Phase I Topic 356 Flourogenic Assay Platform For Circular Rna Detection Pop 9/18/2017 - 6/18/2018.$300K
- Federal grantHealth and Human S · Phase I · Fluorescent reporters for real time single cell Pol III transcription measurement$176K
- Federal grantHealth and Human S · Phase I · Fluorescent reporters for real-time single-cell Pol III transcription measurement$176K
- Federal grantHealth and Human S · Phase II · New toolkit to visualize RNAs in living cells$238K
- Federal grantHealth and Human S · Phase I · Splice sensors for cancer drug discovery$224K
- Federal grantHealth and Human S · Phase I · Splice sensors for cancer drug discovery$224K
- Federal grantHealth and Human S · Phase II · New toolkit to visualize RNAs in living cells$508K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 36 peers
Line = medianBiotech · Platform
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- MAXCYTE, INC.Similar federal contract value in Biotech · $1.9M in contracts
- ABZYME THERAPEUTICS LLCSimilar federal contract value in Biotech · $1.8M in contracts
- INTEGRATED RESEARCH ASSOCIATES, LLCSimilar federal contract value in Biotech · $1.8M in contracts
- Blaze Bioscience, Inc.Similar federal contract value in Biotech · $1.7M in contracts
- ADJUVANCE TECHNOLOGIES INC.Similar federal contract value in Biotech · $1.7M in contracts
- INGENIOUS TARGETING LABORATORY INC.Similar federal contract value in Biotech · $1.7M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .